HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

216 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q3 2020.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 90,857,946 shares of 183,255,226 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (12,884,364 shares), VANGUARD GROUP INC (8,001,099 shares), BAKER BROS. ADVISORS LP (5,994,704 shares), BlackRock Inc. (5,826,318 shares), ArrowMark Colorado Holdings LLC (5,059,526 shares), STATE STREET CORP (4,410,234 shares), WELLINGTON MANAGEMENT GROUP LLP (3,613,296 shares), Clearbridge Investments, LLC (3,436,025 shares), JPMORGAN CHASE & CO (2,978,595 shares), and TANG CAPITAL MANAGEMENT LLC (2,896,904 shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.